Long-term follow-up of remission duration, mortality, and second malignancies in hairy cell leukemia patients treated with pentostatin

Blood

Volumn 96, Issue 9, 2000, Pages 2981-2986

  Flinn, I W ^a   Kopecky, K J ^a   Foucar, M K ^a   Head, D ^a   Bennett, J M ^a   Hutchison, R ^a   Corbett, W ^a   Cassileth, P ^a   Habermann, T ^a   Golomb, H ^a   Rai, K ^a   Eisenhauer, E ^a   Appelbaum, F ^a   Cheson, B ^a   Grever, M R ^a  

^a Southwest Oncology Group   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; NUCLEOSIDE ANALOG; PENTOSTATIN;

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER REGRESSION; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; FEMALE; FOLLOW UP; HAIRY CELL LEUKEMIA; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; OUTPATIENT CARE; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SECOND CANCER;

ADULT; AGED; AGED, 80 AND OVER; ANTIBIOTICS, ANTINEOPLASTIC; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERFERON ALFA-2A; LEUKEMIA, HAIRY CELL; MALE; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; PENTOSTATIN; SURVIVAL RATE;

EID: 0034329819     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Alpha-2 interferon therapy of hairy cell leukemia: A multicenter study of 64 patients
2. Alpha interferon for induction of remission in hairy-cell leukemia
3. Hairy-cell leukemia: Induction of complete remission with pentostatin (2'deoxycoformycin)
4. Low-dose deoxycoformycin in the treatment of hairy cell leukemia
5. Long-lasting complete remission in patients with hairy cell leukemia treated with 2-CdA: A 5-year survey
6. Lasting remissions in hairy-cell leukemia induced by a single infusion of 2-chlorodeoxydenosine
7. Treatment of hairy-cell leukemia with cladribine: Response, toxicity, and long-term follow-up
8. Pentostatin in the treatment of advanced hairy cell leukemia
9. The efficacy of 2'-deoxycoformycin in hairy cell leukemia: A study of the National Cancer Institute of Canada Clinical Trials Group
10. 2-chloredeoxyadenosine induces durable remissions and prolonged suppression of CD4+ lymphocyte counts in patients with hairy cell leukemia
11. Relapse of hairy cell leukemia after 2-chlorodeoxya-denosine: Long-term follow-up of the Northwestern University Experience
12. Long-term follow-up of patients with hairy celt leukemia after treatment with 2'-deoxycoformycin
13. Long term outcome of patients with hairy cell leukemia treated with pentostatin
14. Randomized comparison of pentostatin versus interferon alpha-2a in previously untreated patients with hairy cell leukemia: An intergroup study
15. Increased incidence of second neoplasms in patients treated with interferon alpha 2b for hairy cell leukemia: A clinicopathologic assessment
16. Epidemiology of hairy cell leukemia in Los Angeles County
17. Nonparametric estimation from incomplete observations
18. Evaluation of survival data and two new rank order statistics arising in its consideration
19. Hairy cell leukemia: A clinical review based on 71 cases
20. Second cancer risk in hairy cell leukemia: Analysis of 350 patients
21. Second malignancies as a consequence of nucleoside analog therapy for chronic lymphoid leukemias
22. Long-term follow-up of patients with hairy cell leukemia after cladrabine treatment
23. Treatment of hairy cell leukemia with 2-chlorodeoxya-denosine via the Group C protocol mechanism of the National Cancer Institute: A report of 979 patients